Detection of breast cancer (BrCa) cells in patient peripheral blood stem cell (PBSC) and CD34 selected products using immunocytochemical (ICC) and tumor enrichment procedures.

被引：0
|
作者：
Umiel, T
Prilutskaya, M
Nguyen, NH
Moss, TJ
Burgess, J
Griffith, M
Mills, BJ
机构：
[1] Impath BIS Inc, Reseda, CA USA
[2] Nexell Therapeut Inc, Irvine, CA USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1843
引用
收藏
页码：446A / 446A
页数：1
相关论文
共 50 条
  • [1] Tumor enriched immunocytochemical (ICC) assay for the detection of breast cancer (BrCa) cells in patient peripheral blood stem cell (PBSC) products.
    Umiel, T
    Joyce, R
    Prilutskaya, M
    Vatanparast, R
    Moss, TJ
    BLOOD, 1999, 94 (10) : 143A - 143A
  • [2] Peripheral blood stem cell transplantation in myeloma using CD34 selected cells
    Johnson, RJ
    Owen, RG
    Smith, GM
    Child, JA
    Galvin, M
    Newton, LJ
    Rawstron, A
    Major, K
    Woodhead, V
    Robinson, F
    Jack, A
    Morgan, GJ
    BONE MARROW TRANSPLANTATION, 1996, 17 (05) : 723 - 727
  • [3] The dielectrophoresis enrichment of CD34(+) cells from peripheral blood stem cell harvests
    Stephens, M
    Talary, MS
    Pethig, R
    Burnett, AK
    Mills, KI
    BONE MARROW TRANSPLANTATION, 1996, 18 (04) : 777 - 782
  • [4] Selection and expansion of peripheral blood CD34(+) cells in autologous stem cell transplantation for breast cancer
    Williams, SF
    Lee, WJ
    Bender, JG
    Zimmerman, T
    Swinney, P
    Blake, M
    Carreon, J
    Schilling, M
    Smith, S
    Williams, DE
    Oldham, F
    VanEpps, D
    BLOOD, 1996, 87 (05) : 1687 - 1691
  • [5] CD34 selected allogeneic peripheral blood stem cell (PBSC) transplantation in older patients with advanced hematologic malignancies
    Bensinger, WI
    Rowley, S
    Appelbaum, FR
    Mills, B
    Oldham, F
    Chauncey, T
    Buckner, CD
    BLOOD, 1995, 86 (10) : 376 - 376
  • [6] Peripheral blood (PB) CD34 as a predictor of hematopoietic progenitor cells (HPC) in peripheral blood stem cell (PBSC) collections.
    Areman, EM
    Meehan, KR
    Sacher, RA
    BLOOD, 1997, 90 (10) : 942 - 942
  • [7] Detection of CD20+lymphoma cells in peripheral blood stem cell (PBSC) products using immuno-cytochemical (ICC) and clonogenic assays.
    Moss, TJ
    Fox, RM
    Umiel, T
    Vatanparast, R
    Lazarus, HM
    BLOOD, 1999, 94 (10) : 143A - 143A
  • [8] Immunomagnetic selection of CD34(+) peripheral blood stem cells for autografting in patients with breast cancer
    Hohaus, S
    Pforsich, M
    Murea, S
    Abdallah, A
    Lin, YS
    Funk, L
    Voso, MT
    Kaul, S
    Schmid, H
    Wallwiener, D
    Haas, R
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (04) : 881 - 888
  • [9] Prolonged immunosuppression after CD34(+) or CD34(+)/Thy-1(+)/Lin(*) selected autologous peripheral blood stem cell (PBSC) transplants (Tx) for multiple myeloma
    Siegel, D
    Mehta, J
    Anaissie, E
    Desikan, KR
    Fassas, A
    Jagannath, S
    Singhal, S
    Tricot, G
    Munshi, N
    Barnhart, S
    Hood, S
    Spoon, D
    Mattox, S
    Barlogie, B
    BLOOD, 1997, 90 (10) : 487 - 487
  • [10] The likelihood of successful allogeneic peripheral blood stem cell (PBSC) mobilization is determined by baseline concentration of CD34(+) cells in blood.
    Brown, RA
    Adkins, DR
    Goodnough, L
    Haug, J
    Todd, G
    DiPersio, J
    BLOOD, 1996, 88 (10) : 1597 - 1597
12345